STRAMUCIN DIN 02483459
Status: Marketed
Holder: GLENMARK PHARMACEUTICALS CANADA INC.
Molecule: MUPIROCIN (MUPIROCIN CALCIUM)
Available to quote
Health Canada record
| Active ingredient(s) | MUPIROCIN (MUPIROCIN CALCIUM) 2 % |
|---|---|
| Dosage form | Cream |
| Route | Topical |
| Schedule | NON-PRESCRIPTION DRUGS |
| Class | Human |
| ATC | D06AX09 MUPIROCIN |
| Original market date | 05-Jun-2019 |
| Current status date | 05-Jun-2019 |
| Source | Health Canada DPD |
Establishment licence of the holder
Glenmark Pharmaceuticals Canada Inc. — licence 102261, currently licensed, last inspection rating C (2024-05-14).
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing MUPIROCIN (MUPIROCIN CALCIUM)
| DIN | Product | Company | Form | Strength | Status |
|---|---|---|---|---|---|
| 02239757 | BACTROBAN CREAM | GLAXOSMITHKLINE CONSUMER HEALTHCARE ULC | Cream | MUPIROCIN (MUPIROCIN CALCIUM) 2 % | Cancelled Post Market |
| 02236776 | BACTROBAN NASAL OINTMENT | GLAXOSMITHKLINE INC | Ointment | MUPIROCIN (MUPIROCIN CALCIUM) 2 % | Cancelled Pre Market |
Notices of Compliance
| NOC | Date | Submission | Reason |
|---|---|---|---|
| 21586 | 2018-11-29 | New Drug Submission (NDS) |